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Normal human melanocytes require the synergistic action of several growth-promoting agents for their growth
in serum-free medium. The ability of four representative growth promoting agents including insulin, 12-O-tetrad-
ecanoylphorbol-13-acetate (TPA), basic ﬁbroblast growth factor (bFGF), and 3-isobutyl-1-methylxanthine (IBMX),
(iTbI) to protect melanocytes against apoptosis was examined. Also, the involvement of phosphatidylinositol (PI) 3-
kinase and Akt, one of the downstream targets of PI 3-kinase, in the survival signaling pathway was examined. The
percentage of apoptotic cells was negligible when the cells were grown in the presence of iTbI. Deprivation of iTbI
from the culture medium for 72 h caused 30% of melanocytes to undergo apoptosis and this was suppressed to
variable extents by the addition of one of the iTbI to the medium. Insulin and TPA protected against apoptosis
almost completely, whereas bFGF and IBMX rescued melanocytes from apoptosis to a lesser extent. Wortmannin,
an inhibitor of PI 3-kinase, potently inhibited the protective effect of insulin on melanocytes, whereas it did not
block the ability of TPA, bFGF, or IBMX to rescue the cells from apoptosis. Furthermore, apoptosis of melanocytes
induced by deprivation of iTbI was prevented almost completely by infection with an adenovirus vector encoding a
constitutively active mutant of either PI 3-kinase or Akt. These results indicate that melanocytes can operate both PI
3-kinase/Akt-dependent and -independent mechanisms for protection against apoptosis and that activation of the
PI 3-kinase/Akt pathway is sufﬁcient for protection against apoptosis induced by deprivation of growth-promoting
agents.
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13-acetate
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In vivo, normal human melanocytes are located in the basal
layer of the epidermis and only rarely undergo mitosis (Jim-
bow et al, 1975; Pawelek, 1979). It is conceivable that me-
lanocytes are kept alive by survival signals until they are
stimulated by mitogenic signals such as ultraviolet light
(Quevedo et al, 1965; Rosen et al, 1987). In vitro, me-
lanocytes require the synergistic action of several growth-
promoting agents for their growth in serum-free medium
(Halaban, 2000). Different investigators have used a variety
of factors as growth-promoting agents for melanocytes.
A combination of insulin, 12-O-tetradecanoylphorbol-13-
acetate (TPA), basic fibroblast growth factor (bFGF), and 3-
isobutyl-1-methylxanthine (IBMX), (iTbI) is one of the repre-
sentative combinations of growth-promoting agents for me-
lanocytes (Menrad and Herlyn, 1992). It is possible that
growth-promoting agents play crucial roles in the survival of
melanocytes.
The phosphatidylinositol (PI) 3-kinase is a family of lipid
kinases that phosphorylate the D3 position of the inositol
ring of phosphoinositides (Toker and Cantley, 1997). PI 3-
kinases can be grouped into Class I, II, and III. Class I PI
3-kinases, which are heterodimeric proteins consisting of a
110 kDa catalytic subunit (p110) and an 85 kDa adapter
subunit (p85), have been established as the downstream
effectors of a variety of growth factors. After the binding of
growth factors to their cognate growth factor receptor
tyrosine kinase, Class I PI 3-kinases are recruited to the
plasma membrane and activated. Class I PI 3-kinases are
sensitive to the cell-permeable pharmacological inhibitor of
PI 3-kinase, wortmannin, at relatively low concentrations
(Arcaro and Wymann, 1993).
It has been revealed that a variety of molecules act
downstream of PI 3-kinase. The prime target of the lipid
kinase is the protein-serine/threonine kinase Akt (also
known as PKB), the cellular homologue of a rodent-trans-
forming oncogene product v-Akt (Hemmings, 1997). It is
thought that Akt plays a central role in protecting cells from
apoptosis and promoting cell survival in a wide range of cell
types. Thus, it has generally been accepted that the PI 3-
kinase/Akt pathway is involved in regulating the cell survival
induced by growth factors (Marte and Downward, 1997;
Franke et al, 2003).
In this study, the ability of iTbI to protect melanocytes
from apoptosis was examined. We found that melanocytes
undergo apoptosis after deprivation of iTbI and that each of
Abbreviations: bFGF, basic fibroblast growth factor; DMSO, dime-
thyl sulfoxide; IBMX, 3-isobutyl-1-methylxanthine; iTbI, insulin,
TPA, bFGF, and IBMX; PFU, plaque-forming units; PI, phosphati-
dylinositol; TPA, 12-O-tetradecanoylphorbol-13-acetate
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the iTbI protects the cells against apoptosis to a variable
extent. Next, the involvement of the PI 3-kinase/Akt path-
way in the survival signal induced by each iTbI was exam-
ined. Further, it was determined if activation of PI 3-kinase
or Akt is sufficient for the protection of melanocytes from
apoptosis by using adenovirus vectors encoding consti-
tutively active mutants of PI 3-kinase and Akt. The data
demonstrate the existence of both PI 3-kinase/Akt-depend-
ent and -independent survival signaling pathways in me-
lanocytes.
Results
Deprivation of iTbI from the culture medium induces
apoptosis of melanocytes We first investigated whether
apoptosis is induced in melanocytes by deprivation of iTbI
from the culture medium. The percentage of apoptotic cells
was found to be negligible when the cells were grown in the
presence of iTbI (Fig 1A). A time course study showed that
melanocytes underwent apoptosis after the deprivation of
iTbI in a time-dependent manner and the rate of apopto-
sis reached enrichment factor 3, which corresponds to
20%–30% of total cells at 72 h after the deprivation of iTbI
(Fig 1A). Time-dependent increase of apoptosis by deprivation
of iTbI was also demonstrated by flow cytometric analysis
(Fig 1B). Flow cytometric analysis indicated that necrotic
cells were almost absent in melanocytes cultured in com-
plete medium and that deprivation of iTbI did not signifi-
cantly increase the percentage of necrotic cells (Fig 1B).
Each of the iTbI protects melanocytes against apopto-
sis To determine whether iTbI can act as survival factors for
melanocytes, the effect of each of the iTbI on apoptosis was
quantified (Fig 2). Apoptosis induced by the deprivation of
iTbI was suppressed by the addition of one of the iTbI into
standard medium in a concentration-dependent manner,
although the potency of protection against apoptosis dif-
fered among the iTbI. Insulin and TPA protected apoptosis
almost completely at 5 mg per mL and 10 ng per mL, re-
spectively. The ability of bFGF and IBMX to protect against
apoptosis reached a plateau at 3 ng per mL and 100 mM,
respectively, and was less than that of insulin or TPA, even
at the maximal dose used.
Insulin protects melanocytes against apoptosis through
PI 3-kinase The involvement of PI 3-kinase in the iTbI-
induced protection against apoptosis was examined. As
shown in Fig 3A, the PI 3-kinase inhibitor, wortmannin, po-
tently inhibited insulin-induced protection against apopto-
sis, whereas the protective effects of TPA, bFGF, and IBMX
were not affected. The effect of insulin on PI 3-kinase ac-
tivity was then examined. As shown in Fig 3B, insulin clearly
activated PI 3-kinase, and this was blocked in the presence
of wortmannin. These results suggest that the activation of
PI 3-kinase is involved in the protective effect of insulin but
not of other growth-promoting agents.
Activation of PI 3-kinase protects against apoptosis in
melanocytes To further investigate the role of PI 3-kinase
in the protection against apoptosis in melanocytes, the ef-
fect of the constitutively active mutant of PI 3-kinase (Myr-
p110), on apoptosis was examined. Myr-p110 is a chimeric
protein consisting of the catalytic subunit of PI 3-kinase
(p110) ligated to a myristration signal sequence at its amino
terminal and with Myc epitope at its carboxy terminal.
Infection of the cells with 25 plaque-forming units (PFU) per
cell of AxCAMyr-p110 resulted in an increase in PI 3-kinase
activity (Fig 4A) and caused almost complete inhibition of
apoptosis (Fig 4B). Infection of melanocytes with the control
Figure 1
Effect of deprivation of iTbI (insulin, TPA, bFGF, and IBMX) on apoptosis in melanocytes. Melanocytes were transferred into either standard
medium (solid bar in A) or complete medium (open bar in A and ‘‘complete’’ in B), which consists of standard medium additionally supplemented
with iTbI. The induction of apoptosis was examined at the indicated time points. (A) Cytoplasmic fractions prepared from cell lysates were used for
quantitation of the nucleosome using cell death detection ELISA. po0.01 versus cells maintained in complete medium for 72 h. (B) Apoptosis was
also examined by flow cytometric analysis. The lower right quadrants represent the apoptotic cells, stained with Annexin V but not propidium iodide,
demonstrating cytoplasmic membrane integrity. The upper right quadrants show the non-viable, necrotic cells, positively stained with both Annexin
V and propidium iodide. The percentage of apoptotic and necrotic cells is shown in lower right and upper right quadrants, respectively.
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adenovirus AxLacZ altered neither the basal PI 3-kinase
activity nor the apoptosis level (Fig 4A, B). These results
indicate that activation of PI 3-kinase is sufficient for pro-
tection against apoptosis induced by the deprivation of iTbI.
Activation of Akt protects against apoptosis in me-
lanocytes The role of Akt in the protection against
apoptosis in melanocytes was examined. It was confirmed
that 5 mg per mL insulin activates Akt by showing an in-
crease in the active (phosphorylated) form of Akt in me-
lanocytes (Fig 5A). Infection of the cells with 5 PFU per cell
of AxCAMyr-Akt increased the level of the active form of Akt
(Fig 5B) and inhibited apoptosis almost completely (Fig 5C).
Infection of the cells with the control adenovirus AxLacZ did
not affect either the basal Akt activity or the apoptosis level
at the PFU used in this study (Fig 5B, C). These results
indicate that activation of Akt can rescue melanocytes from
apoptosis induced by the deprivation of iTbI.
Discussion
Melanocytes express the insulin receptor and the insulin-
like growth factor-1 receptor (Herlyn et al, 1987), both of
which can be activated by insulin. Thus, it is possible that
insulin activates the PI 3-kinase/Akt pathway through both
receptors, resulting in the protection of melanocytes against
apoptosis in vitro. It is unlikely, however, that insulin is the
major stimulator of the PI 3-kinase/Akt pathway in vivo since
a much higher concentration of insulin than the physiolog-
ical concentration is needed for the efficient protection of
melanocytes against apoptosis (data not shown). Identifi-
cation of physiological activators of the PI 3-kinase/Akt
pathway linked to the survival of melanocytes in vivo would
Figure 2
Protection against apoptosis in melanocytes by iTbI. Melanocytes
were transferred into complete medium, standard medium, or standard
medium containing various doses of insulin, TPA, bFGF, or IBMX, and
cultured for 72 h. The induction of apoptosis was examined and shown
by enrichment factors. po0.01, po0.05 versus cells maintained in
standard medium.
Figure3
Involvement of PI 3-kinase in the protection against apoptosis
by insulin. (A) Inhibition of the insulin-induced protection against
apoptosis in melanocytes by wortmannin. Melanocytes were preincu-
bated with (þW) or without 100 nM PI 3-kinase inhibitor wortmannin for
30 min in standard medium, and then 5 mg per mL insulin, 10 ng per mL
TPA, 3 ng per mL bFGF, or 100 mM IBMX was added to the medium,
and cultured for 72 h. DMSO (þD) (0.1%) was used as the control for
wortmannin. The induction of apoptosis was examined and shown by
enrichment factors. The induction of apoptosis in melanocytes, which
were cultured in either complete or standard medium for 72 h was also
examined. po0.01 versus cells pretreated with DMSO and then cul-
tured in the presence of insulin. (B) Activation of PI 3-kinase by insulin
and inhibition of insulin-induced PI 3-kinase activation by wortmannin.
Melanocytes were pre-incubated with or without 100 nM wortmannin
for 30 min in standard medium and then treated with 5 mg per mL insulin
for 5 min. Cell lysates were prepared and subjected to immunoprecip-
itation with PY20. The immunoprecipitates were assayed for PI 3-kin-
ase activity. Upper panel, representative thin layer chromatography of
the PI3K assay from three independent experiments. The positions of
the origin and PI(3)P are indicated. Lower panel, relative increase in
PI3K activity induced by insulin. The relative PI 3-kinase activity was
expressed as a percentage of untreated control cells (¼100%). Data
are means  SD from three experiments. po0.01 versus untreated
control cells.
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be helpful for further understanding of the significance of
the PI 3-kinase/Akt-dependent protection against apoptosis
in the cells.
The signaling pathways responsible for the protection
against apoptosis in melanocytes provided by TPA, bFGF,
and IBMX have not been identified in this study. Wortmannin
did not affect the protective effects of TPA, bFGF, or IBMX
on melanocytes and Akt was not activated by treatment
with these growth-promoting agents (data not shown), in-
dicating that TPA, bFGF, and IBMX suppress apoptosis of
melanocytes through a PI 3-kinase/Akt-independent path-
way. Arita et al (2000) showed that TPA protects me-
lanocytes against apoptosis and suggested that protein
kinase C, which is the major intracellular receptor for TPA
(Nishizuka, 1986), plays an important role in the inhibition
of apoptosis in the cells. The ability of bFGF to protect
melanocytes from apoptosis has been demonstrated by
Alanko et al (1999), although the signaling pathway respon-
sible for this was not examined. Since cyclic-AMP enhanc-
ers, such as IBMX, activate protein kinase A, and it has
been shown that this protein kinase protects against
apoptosis in some cell types (Reshkin et al, 2003; Simon
et al, 2003), protein kinase A is a candidate for the effector
of the survival signal induced by IBMX in melanocytes. Re-
cently, Kim et al (2003) have shown that both extracellular
signal-regulated protein kinase and Akt regulate mouse
melanocyte survival. These reports and our present results
suggest that melanocytes possess diverse signaling path-
ways, including PI 3-kinase/Akt, for protection against
apoptosis.
We have shown that activation of PI 3-kinase or Akt is
sufficient for the protection of melanocytes against apop-
tosis induced by the deprivation of growth-promoting
agents. It has been shown, however, that melanocytes are
stimulated to undergo apoptosis by ways other than the
deprivation of growth-promoting agents, such as ultraviolet
irradiation (Zhai et al, 1996; Sauer et al, 2003), and treatment
with tumor-necrosis factor (Sauer et al, 2003), or Fas
(Sharov et al, 2003). It is important to determine if activa-
tion of PI 3-kinase or Akt is also effective in the suppression
of apoptosis induced by other ways than the deprivation
of growth-promoting agents. As mentioned above, me-
lanocytes may possess a variety of signaling pathways for
protection against apoptosis. It is an attractive idea that
melanocytes operate the most efficient survival signal(s) to
counteract each type of damage causing apoptosis, whe-
ther in isolation or synergistically.
Activation of Akt has been implicated in the tumor pro-
gression of melanoma by inducing apoptosis resistance in
melanoma cells (Satyamoorthy et al, 2001; Dhawan et al,
2002; Li et al, 2003; Stahl et al, 2003). Conversely, it has
been shown that Akt regulates the proliferation of Malme-
3M melanoma cells without affecting apoptosis (Han et al,
2002). These reports suggest that activation of Akt is an
important survival signal in both melanoma cells and me-
lanocytes, and that Akt regulates not only apoptosis but
also proliferation in melanoma cells.
A number of mechanisms by which Akt suppresses
apoptosis have been described (Datta et al, 1999; Franke
et al, 2003). These include phosphorylation and the conse-
quent inactivation of pro-apoptotic proteins such as BAD,
members of the forkhead family of transcription factors and
caspase-9, and activation of anti-apoptotic proteins such
as NF-kB. Other targets for Akt, including glycogen synt-
hase kinase-3b, telomerase, and NOS may also play crucial
roles in cellular survival. Further studies are necessary to
elucidate the exact downstream steps of the PI 3-kinase/
Akt pathway leading to the protection of melanocytes from
apoptosis.
Figure 4
Effects of Myr-p110 on PI 3-kinase activity and apoptosis in me-
lanocytes. Melanocytes were infected with or without 25 PFU per cell
of AxCAMyr-p110 or AxLacZ, and 24 h after the infection, cells were
transferred into standard (standard) or complete (complete) medium,
and cultured for 72 h. (A) Cell lysates were prepared and subjected
to immunoprecipitation with antibodies directed against Myc. The
immunoprecipitates were assayed for PI 3-kinase activity. Upper panel,
representative thin layer chromatography of PI3K assay from three in-
dependent experiments. The positions of the origin and PI(3)P are in-
dicated. Lower panel, relative increase in PI3K activity induced by Myr-
p110. The relative PI 3-kinase activity was expressed as a percentage
of uninfected control cells (¼ 100%). Data are means  SD from three
experiments. po0.01 versus cells infected with AxLacZ. (B) The in-
duction of apoptosis was examined and shown by enrichment factors.
po0.01 versus cells infected with AxLacZ.
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Materials and Methods
Cells and treatment Melanocytes from neonatal Caucasian fore-
skins were obtained from Kurabo Industry (Osaka, Japan). ‘‘Stand-
ard medium’’ consisted of basal nutrient medium 154S (Kurabo)
supplemented with 0.1 mM ethanolamine, 0.1 mM phospho-
ethanolamine, 0.5 mM hydrocortisone, 5 mg per mL transferrin, and
3 mg per mL heparin, and was used for the induction of apoptosis
in melanocytes. ‘‘Complete medium’’ consisted of standard medi-
um additionally supplemented with growth-promoting agents for
melanocytes including 5 mg per mL insulin, 10 ng per mL TPA, 3 ng
per mL recombinant human bFGF, and 100 mM IBMX, and was
used for the culture of melanocytes. The four growth-promoting
agents, namely insulin, TPA, bFGF, and IBMX, were designated
iTbI. For evaluation of the effects of the iTbI on apoptosis, me-
lanocytes were washed three times with phosphate-buffered sa-
line, and transferred into either complete medium, standard
medium, or standard medium containing one of the iTbI for the
indicated period. Where indicated, cells were treated with wo-
rtmannin (Sigma, St Louis, Missouri) dissolved in dimethyl sulfoxide
(DMSO). The medium containing iTbI and/or wortmannin was
changed every 24 h.
Detection of apoptosis To evaluate apoptosis, the cell death de-
tection ELISA kit (Cell Death Detection ELISA, Roche Diagnostics,
Tokyo, Japan) was used according to the manufacturer’s instruc-
tions. In principle, this assay is based on the detection of mono-
and oligonucleosomes in the cytoplasmic fraction of the cell
lysates using biotinylated anti-histone and peroxidase-coupled
anti-DNA antibodies. Melanocytes were detached from the dishes
by scraping, recovered by centrifugation, and resuspended in
phosphate-buffered saline at room temperature. The enrichment of
mono- and oligonucleosomes released into the cytoplasm was
calculated as absorbance of the sample cells/absorbance of the
control cells. The enrichment factor was used as a parameter of
apoptosis. Enrichment factor 1 of the Cell Death Detection ELISA
corresponds to 7%–11% of dead cells as determined by flow
cytometric analysis detecting sub-G1 DNA fragments after staining
with propidium iodide (Sigma) using Cyto ACE-300 (Jasco, Tokyo,
Japan). The assays were performed three times, and data are
shown as mean  SD. Apoptotic cell death was also analyzed by
flow cytometry as described previously (Vermes et al, 1995). Brief-
ly, cells were harvested, spun down, and washed three times with
cold phosphate-buffered saline. The cells were resuspended in
10 mM HEPES, pH 7.4, containing 0.14 M NaCl and 2.5 mM CaCl2
at a concentration of 1  106 cells per mL, and were stained
with Annexin V-FITC (BD Pharmingen, San Diego, California) in
conjunction with the vital dye, propidium iodide. Apoptosis of cells
was analyzed using a FACSCalibur flow cytometer (BD, San Jose,
California).
Adenovirus vectors and infection Adenovirus vectors encoding
the constitutively active mutants of PI 3-kinase (Myr-p110) and Akt
(Myr-Akt) were developed as described previously (Kitamura et al,
1999) and termed AxCAMyr-p110 and AxCAMyr-Akt, respectively.
Myr-p110 is a chimeric protein consisting of the catalytic subunit of
PI 3-kinase (p110) ligated to a myristoylation signal sequence at its
amino terminal, with the Myc epitope at its carboxyl terminal. It has
been demonstrated that the expression of Myr-p110 in cells results
in an increase in PI 3-kinase activity independent of cell stimulation
and acts as a constitutively active form of PI 3-kinase (Kotani et al,
1999). It has been demonstrated that Myr-Akt, which contains a
myristoylation signal sequence at its amino terminal, is phosphory-
lated independently of cell stimulation when expressed in cells and
shows much higher kinase activity than the wild-type enzyme
(Kohn et al, 1996). The adenovirus carrying the b-galactosidase
gene (LacZ) from Escherichia coli (Kanegae et al, 1995) was des-
ignated AxLacZ and used as a control virus. Melanocytes were
infected with adenovirus vectors in complete medium, and 24 h
Figure 5
Activation of Akt kinase activity by insulin and effects of Myr-Akt
on Akt kinase activity and apoptosis in melanocytes. (A) Me-
lanocytes were treated with 5 mg per mL insulin for 5 min. Cell lysates
were prepared and subjected to immunoblot analysis with either anti-
Akt or anti-phospho-Akt antibody. The increase in phospho-Akt com-
pared with untreated cells was determined by densitometric analysis
and is shown in the lower panel. po0.01 versus untreated control
cells. (B, C) Melanocytes were infected with or without 5 PFU per cell of
AxCAMyr-Akt or AxLacZ, and 24 h after the infection, cells were trans-
ferred into standard (standard) or complete (complete) medium, and
cultured for 72 h. Cell lysates were prepared and subjected to immuno-
blot analysis with either anti-phospho-Akt or anti-Akt antibody (B, up-
per and middle panels). The increase in phospho-Akt compared with
uninfected cells was determined by densitometric analysis and is
shown in the lowest panel (B, lower panel). po0.01 versus cells in-
fected with AxLacZ. The induction of apoptosis was examined and
shown by enrichment factors (C). po0.01 versus cells infected with
AxLacZ.
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after the infection, cells were transferred into standard medium for
evaluation of apoptosis.
PI 3-kinase assay PI 3-kinase activity was measured as de-
scribed by Endemann et al (1990). The cells (approximately
1  106 cells) were lysed in 20 mM Tris-HCl, pH 7.6, containing
1% (wt/vol) Nonidet P-40, 10% (vol/vol) glycerol, 137 mM NaCl,
1 mM MgCl2, 1 mM CaCl2, 1 mM dithiothreitol, 1 mM phenyl-
methylsulfonyl fluoride, and 1 mM sodium orthovanadate. The
lysate was centrifuged, and the supernatant was subjected to
immunoprecipitation with a monoclonal antibody against either
phosphotyrosine (PY20, Transduction Laboratories, Lexington,
Kentucky) or Myc (Santa Cruz Biotechnology, Santa Cruz, Califor-
nia). The immunoprecipitate was incubated with 0.2 mg per mL PI
for 5 min at room temperature, and the PI 3-kinase reaction was
carried out in reaction mixture (50 mL) containing 20 mM HEPES,
pH 7.1, 50 mM MgCl2, and 250 mM [g-
32P]adenosine-50-tripho-
sphate (ATP). The reaction was stopped by the addition of 15 mL of
4 N HCl and 130 mL of chloroform:methanol (1:1). Tubes were
mixed for 30 s, and 20 mL of the lower layer was subjected to thin-
layer chromatography in chloroform/methanol/4M ammonium hy-
droxide (9:7:2). The generation of radioactive PI(3)P was detected
and the radioactivity of PI(3)P was quantitated using a bioimaging
analyzer (BAS 2000, Fuji Film, Tokyo, Japan) for statistical analysis.
Immunoblot analysis Cells plated out into 10 cm tissue culture
dishes were infected with various doses of adenovirus. At 24 h
after infection, cells were washed three times with phosphate-
buffered saline and lysed in 20 mM Tris-HCl, pH 7.5, containing 1
mM EDTA, 1 mM EGTA, 10 mM 2-mercaptoethanol, 1% (wt/vol)
Triton X-100, 150 mM NaCl, 10 mM NaF, 1 mM sodium ortho-
vanadate, and 50 mg per mL phenylmethylsulfonyl fluoride. The cell
lysate was centrifuged for 10 min at 15,000  g at 41C and the
supernatants were separated by 10% SDS-PAGE, and transferred
onto an Immobilon P membrane (Millipore, Bedford, Massachu-
setts). After blocking with 5% bovine serum albumin, the mem-
brane was incubated with either anti-Akt (Cell Signaling
Technology, Beverly, Massachusetts) or anti-Ser473 phospho-Akt
antibody (Cell Signaling Technology) as the primary antibody. The
membrane was then incubated with an alkaline phosphatase-con-
jugated anti-rabbit antibody as the secondary antibody. The color
reaction was carried out using 5-bromo-4-chloro-3-indoyl-
phosphate and nitro blue tetrazolium as substrates, as described
(Konishi et al, 1997). Data shown are representative of three inde-
pendent experiments.
Statistics Differences between results were assessed for signif-
icance using the Student’s t test.
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